Cargando…
MYC Is a Major Determinant of Mitotic Cell Fate
Taxol and other antimitotic agents are frontline chemotherapy agents but the mechanisms responsible for patient benefit remain unclear. Following a genome-wide siRNA screen, we identified the oncogenic transcription factor Myc as a taxol sensitizer. Using time-lapse imaging to correlate mitotic beha...
Autores principales: | Topham, Caroline, Tighe, Anthony, Ly, Peter, Bennett, Ailsa, Sloss, Olivia, Nelson, Louisa, Ridgway, Rachel A., Huels, David, Littler, Samantha, Schandl, Claudia, Sun, Ying, Bechi, Beatrice, Procter, David J., Sansom, Owen J., Cleveland, Don W., Taylor, Stephen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518499/ https://www.ncbi.nlm.nih.gov/pubmed/26175417 http://dx.doi.org/10.1016/j.ccell.2015.06.001 |
Ejemplares similares
-
Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers
por: Bennett, Ailsa, et al.
Publicado: (2016) -
Oncogenic MYC amplifies mitotic perturbations
por: Littler, Samantha, et al.
Publicado: (2019) -
Cenp-E inhibitor GSK923295: Novel synthetic route and use as a tool to generate aneuploidy
por: Bennett, Ailsa, et al.
Publicado: (2015) -
Mcl-1 dynamics influence mitotic slippage and death in mitosis
por: Sloss, Olivia, et al.
Publicado: (2016) -
A link between mitotic defects and mitotic catastrophe: detection and cell fate
por: Sazonova, Elena V., et al.
Publicado: (2021)